Confirmation week turns negative for the fresh signal
Recursion Pharmaceuticals slides 6.3% as confirmation week hands control to sellers
Confirmation week turns negative for the fresh signal
Our view last week
Recursion Pharmaceuticals opens a fresh buy signal, 7th among the 10 fresh Longs for US stocks, with a signal strength of 76 out of 100. The technical picture is wide but volatile: high conviction, ample move, to be managed with discipline. Behind it, a double bottom with a 44% rebound, and a Health Care sector up nearly 12% over the past month. The entry stays cautious: the stock has not yet attacked its recent highs.
This week's summary
Recursion Pharmaceuticals' fresh buy signal closes its first week down 6.3%: sellers are back in control of the volume and the weekly structure is flashing early fatigue signs, even with a double bottom in the 3.0 area and a 37% rebound still behind it. This week's technical analysis flags caution from the confirmation, in a Health Care sector still running strong — one to watch for swing trading setups.
IQS Phase
40
ordinary
Signal Strength
79
high · wide & volatile
Sizing
FULL
Ranking
#45 / 129
US stocks in progress
Trade P&L %
-6.32%
from signal to today
restricted Platinum content